Media Coverage header image
 |
|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
The FDA has given emergency use authorization for a COVID-19 and flu combination diagnostic from Quest Diagnostics.
The use of illicit fentanyl and heroin rose dramatically during the first two months of the COVID-19 pandemic, according to a large new study by Quest Diagnostics.
Misuse of fentanyl, heroin and nonprescribed opioids are on the rise, potentially due to the COVID-19 pandemic's impact on healthcare access and support for individuals most at-risk for substance use disorder, suggests a study from Quest Diagnostics Health Trends and summarized in a press release.
A decline in mammograms and other screening procedures after the coronavirus pandemic struck is leading to missed and delayed cancer diagnoses, according to data from insurance claims, lab orders, Medicare billings and oncology-practice records.
Mobile app Health Pass securely connects a person's verified identity with real-time surveys, data from temperature checks and now, verified diagnostics from the Secaucus-based laboratory.